Press release
Elevation to be the buzzword of Intravitreal Ivt Injectable Market between 2022-2028, reaching US$ 23,814.3 Mn
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete blindness. Intravitreal injection is a safe and easy method of treating retinal disorders.
Company Profiles:
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906
According to the National Eye Institute (NEI), around 2.0 million people in the United States were afflicted by AMD in 2010, with the figure anticipated to more than increase to 5.4 million by 2050. To address rising demand, industry players are focused on innovation by developing a solid pipeline of IVT injections for the treatment of retinal diseases.
Between 2022 and 2028, North America is expected to account for a significant share of the global market. Increased incidence of age-related macular degeneration (AMD) is expected to stimulate demand for intravitreal (IVT) injectables in the United States.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906
Due to an increase in the elderly population and an increase in the incidence of retinal illnesses, the European market is also expected to fuel market growth. In the coming years, countries such as India and China are likely to boost demand for intravitreal (IVT) injectables in the Asia Pacific region, due to the presence of a sizable patient pool suffering from diabetes mellitus.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp
Want More Insights?
PMR has presented a comprehensive report based on Intravitreal (IVT) Injectable Market as per Indication (Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others), Drug Class (Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals), Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies and Others), based on seven regions.
Related Reports:
Pharmaceutical Excipients For Taste Masking Market - https://www.persistencemarketresearch.com/market-research/pharmaceutical-excipients-for-taste-masking-market.asp
Medical Marijuana Market - https://www.persistencemarketresearch.com/market-research/medical-marijuana-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevation to be the buzzword of Intravitreal Ivt Injectable Market between 2022-2028, reaching US$ 23,814.3 Mn here
News-ID: 2632617 • Views: …
More Releases from Persistence Market Research
Anti-Aging Products Market to Reach US$90.8 Bn by 2032 Driven by Skincare Demand
The global anti-aging products market is poised for significant expansion over the forecast period, driven by a growing awareness of skincare and wellness across diverse demographics. The market is projected to be valued at US$53.7 billion in 2025 and is estimated to reach US$90.8 billion by 2032, registering a robust compound annual growth rate (CAGR) of 7.8% during the period from 2025 to 2032. Increasing consumer inclination towards preventive and…
Sports Tourism Market to Reach US$ 1,212 Bn by 2032, Driven by Rising Travel & E …
The global sports tourism market is anticipated to experience substantial growth over the forecast period from 2025 to 2032. Valued at approximately US$ 702.6 billion in 2025, the market is projected to reach US$ 1,212 billion by 2032, registering a robust compound annual growth rate (CAGR) of 8.1% during the forecast period. This impressive growth is being fueled by a confluence of factors, including increasing disposable incomes, a growing emphasis…
Perfume Market to Reach US$ 83.5 Bn by 2032 Driven by Rising Luxury & Personal C …
The global perfume market was valued at US$ 55.9 billion in 2025 and is projected to reach US$ 83.5 billion by 2032, registering a robust compound annual growth rate (CAGR) of 5.9% during the forecast period from 2025 to 2032. This sustained growth is driven by increasing consumer awareness regarding personal grooming, the rising demand for luxury and premium fragrances, and the expanding influence of social media on lifestyle and…
Recyclable Packaging Market to Gain Traction and Reach US$ 286.3 billion in 2032
In recent years, the global packaging industry has undergone a profound transformation. This change is largely driven by the increasing demand for sustainable solutions and heightened environmental awareness among consumers and businesses. Traditional packaging methods, often reliant on single-use plastics or non-recyclable materials, are being re-evaluated in light of their environmental impact. Today, recyclable packaging is no longer a peripheral consideration but has become a central focus for companies seeking…
More Releases for Intravitreal
Intravitreal Injectable Market Key Players, Share and Forecast Outlook
"The global intravitreal injectable market is valued at approximately $9.1 billion in 2024, driven by a surge in age-related macular degeneration and diabetic retinopathy cases. The market is expected to grow, reaching an estimated $15.3 billion by 2034, reflecting increasing demand for innovative therapies. This represents a Compound Annual Growth Rate (CAGR) of approximately 5.3% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled…
Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic…
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview:
The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections.
Market Dynamics:
Growing Prevalence of Cataracts: Cataracts, which are the primary cause of…
The Intravitreal Injectable Market To Prove Its Servility To Technological Advan …
The market for intravitreal injectables was expected to be worth US$ YY million in 2021 and would likely reach US$ YY million by 2029, expanding at a CAGR of 5.8% over the forecast period (2023-2032). The vitreous cavity, which is filled with a fluid referred to as the vitreous humour gel, is the location where medication is directly injected during intravitreal injection. Steroids and anti-VEGF medications aid in reducing fluid…
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete…
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing…
